align technology inc. - ALGN

ALGN

Close Chg Chg %
134.70 4.42 3.28%

Pre-Market

139.12

+4.42 (3.28%)

Volume: 1.06M

Last Updated:

Sep 5, 2025, 4:00 PM EDT

Company Overview: align technology inc. - ALGN

ALGN Key Data

Open

$135.11

Day Range

135.11 - 139.18

52 Week Range

127.70 - 262.77

Market Cap

$9.76B

Shares Outstanding

72.49M

Public Float

67.88M

Beta

1.65

Rev. Per Employee

N/A

P/E Ratio

22.72

EPS

$5.93

Yield

0.00%

Dividend

N/A

EX-DIVIDEND DATE

SHORT INTEREST

N/A

AVERAGE VOLUME

1.44M

 

ALGN Performance

1 Week
 
-2.00%
 
1 Month
 
-0.54%
 
3 Months
 
-22.98%
 
1 Year
 
-37.09%
 
5 Years
 
-54.98%
 

ALGN Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings 18
Full Ratings ➔

About align technology inc. - ALGN

Align Technology, Inc. is a medical device company, which engages in the design, manufacture, and market of orthodontics, restorative, and aesthetic dentistry products. It operates through the Clear Aligner and Systems and Services segments. The Clear Aligner segment consists of invisalign full, teen, and assist products, and Vivera retainers for treating malocclusion. The Systems and Services segment includes sales related to iTero intraoral scanning systems, which includes a single hardware platform and restorative or orthodontic software options, upgrades and leases of scanner systems, sales of pre-owned scanner systems, subscription software, disposables, pay per scan services, as well as exocad’s CAD/CAM software solutions that integrate workflows to dental labs and dental practices. The company was founded by Zia Chishti, Brian Freyburger, and Kelsey Wirth in March 1997 and is headquartered in Tempe, AZ.

ALGN At a Glance

Align Technology, Inc.
410 North Scottsdale Road
Tempe, Arizona 85288
Phone 1-602-742-2000 Revenue 4.00B
Industry Medical Specialties Net Income 421.36M
Sector Health Technology 2024 Sales Growth 3.541%
Fiscal Year-end 12 / 2025 Employees 20,945
View SEC Filings

ALGN Valuation

P/E Current 22.722
P/E Ratio (with extraordinary items) N/A
P/E Ratio (without extraordinary items) 37.11
Price to Sales Ratio 3.91
Price to Book Ratio 3.997
Price to Cash Flow Ratio 21.181
Enterprise Value to EBITDA 18.012
Enterprise Value to Sales 3.679
Total Debt to Enterprise Value 0.008

ALGN Efficiency

Revenue/Employee 190,929.196
Income Per Employee 20,117.546
Receivables Turnover 3.884
Total Asset Turnover 0.65

ALGN Liquidity

Current Ratio 1.223
Quick Ratio 1.098
Cash Ratio 0.512

ALGN Profitability

Gross Margin 70.545
Operating Margin 16.798
Pretax Margin 15.228
Net Margin 10.537
Return on Assets 6.852
Return on Equity 11.263
Return on Total Capital 10.61
Return on Invested Capital 10.991

ALGN Capital Structure

Total Debt to Total Equity 3.097
Total Debt to Total Capital 3.004
Total Debt to Total Assets 1.919
Long-Term Debt to Equity 2.29
Long-Term Debt to Total Capital 2.221
  • Income Statement
  • Balance Sheet
  • Cash Flow Statement

Annual Financials for Align Technology Inc. - ALGN

Collapse All in section
All values USD millions. 2021 2022 2023 2024 5-year trend
Sales/Revenue
3.95B 3.73B 3.86B 4.00B
Sales Growth
+59.90% -5.51% +3.42% +3.54%
Cost of Goods Sold (COGS) incl D&A
999.02M 1.08B 1.14B 1.18B
COGS excluding D&A
- - - -
-
Depreciation & Amortization Expense
135.51M 156.32M 142.40M 145.03M
Depreciation
118.91M 140.32M 126.00M 126.13M
Amortization of Intangibles
16.60M 16.00M 16.40M 18.90M
COGS Growth
+43.51% +8.55% +4.86% +3.58%
Gross Income
2.95B 2.65B 2.73B 2.82B
Gross Income Growth
+66.32% -10.27% +2.83% +3.52%
Gross Profit Margin
+74.72% +70.96% +70.56% +70.55%
2021 2022 2023 2024 5-year trend
SG&A Expense
1.96B 1.98B 2.05B 2.13B
Research & Development
250.31M 305.26M 346.83M 364.20M
Other SG&A
1.71B 1.67B 1.70B 1.76B
SGA Growth
+42.36% +1.06% +3.56% +3.76%
Other Operating Expense
18.21M 16.43M 18.25M 21.96M
Unusual Expense
(43.40M) 11.45M 13.32M 28.94M
EBIT after Unusual Expense
1.02B 642.60M 643.34M 642.83M
Non Operating Income/Expense
(7.38M) (43.54M) (2.13M) (33.87M)
Non-Operating Interest Income
3.10M 5.37M 17.26M 20.22M
Equity in Earnings of Affiliates
- - - -
-
Interest Expense
- - - -
-
Interest Expense Growth
- - - -
-
Gross Interest Expense
- - - -
-
Interest Capitalized
- - - -
-
Pretax Income
1.01B 599.06M 641.20M 608.96M
Pretax Income Growth
+167.17% -40.83% +7.04% -5.03%
Pretax Margin
+25.61% +16.04% +16.60% +15.23%
Income Tax
240.40M 237.48M 196.15M 187.60M
Income Tax - Current - Domestic
185.75M 222.67M 162.87M 108.73M
Income Tax - Current - Foreign
42.68M 56.54M 51.31M 56.65M
Income Tax - Deferred - Domestic
(31.46M) (67.84M) (19.96M) 4.96M
Income Tax - Deferred - Foreign
43.43M 26.12M 1.94M 17.25M
Income Tax Credits
- - - -
-
Equity in Earnings of Affiliates
- - - -
-
Other After Tax Income (Expense)
- - - -
-
Consolidated Net Income
772.02M 361.57M 445.05M 421.36M
Minority Interest Expense
- - - -
-
Net Income
772.02M 361.57M 445.05M 421.36M
Net Income Growth
-56.53% -53.17% +23.09% -5.32%
Net Margin Growth
+19.53% +9.68% +11.52% +10.54%
Extraordinaries & Discontinued Operations
- - - -
-
Discontinued Operations
- - - -
-
Net Income After Extraordinaries
772.02M 361.57M 445.05M 421.36M
Preferred Dividends
- - - -
-
Net Income Available to Common
772.02M 361.57M 445.05M 421.36M
EPS (Basic)
9.7827 4.6243 5.8233 5.6274
EPS (Basic) Growth
-56.61% -52.73% +25.93% -3.36%
Basic Shares Outstanding
78.92M 78.19M 76.43M 74.88M
EPS (Diluted)
9.6902 4.6107 5.8125 5.6187
EPS (Diluted) Growth
-56.77% -52.42% +26.07% -3.33%
Diluted Shares Outstanding
79.67M 78.42M 76.57M 74.99M
EBITDA
1.11B 810.37M 799.05M 816.80M
EBITDA Growth
+120.99% -27.12% -1.40% +2.22%
EBITDA Margin
+28.13% +21.70% +20.69% +20.42%

Snapshot

Average Recommendation OVERWEIGHT Average Target Price 183.769
Number of Ratings 18 Current Quarters Estimate 2.433
FY Report Date 09 / 2025 Current Year's Estimate 10.101
Last Quarter’s Earnings 2.49 Median PE on CY Estimate N/A
Year Ago Earnings 9.33 Next Fiscal Year Estimate 10.881
Median PE on Next FY Estimate N/A

Earnings Per Share

This Quarter Next Quarter This Fiscal Next Fiscal
# of Estimates 14 14 15 15
Mean Estimate 2.43 3.05 10.10 10.88
High Estimates 2.72 3.26 10.42 11.45
Low Estimate 2.28 2.82 9.80 10.47
Coefficient of Variance 4.79 5.05 1.62 2.69

Analysts Recommendations

Current 1 Month Ago 3 Months Ago
BUY 10 10 11
OVERWEIGHT 2 2 2
HOLD 5 5 4
UNDERWEIGHT 1 1 2
SELL 0 0 0
MEAN Overweight Overweight Overweight

Align Technology Inc. in the News